The Institute for Cancer Care Innovation focuses on the principles of value-based health care delivery by implementing outcome measurement, measuring the cost of cancer care, and enabling programs that increase the value of care delivery.
Assist institutional providers and programs to develop and implement innovative value-based cancer care programs.
Enhanced Recovery Programs
Value of Care Analysis
Patient and Provider Outcome Development
Value-Based Care Education
MD Anderson Tumor Registry
The Tumor Registry at MD Anderson contains high quality demographic, disease, and follow- up information for all patients assigned a medical record number at MD Anderson, starting with the first patient registered on March 1, 1944.
Clinical Effectiveness Department
The Clinical Effectiveness department’s mission is to develop, implement, maintain, support and evaluate evidence-based patient care management tools intended to enhance the delivery of safe, effective, and consistent health care across the care continuum.
Thomas Aloia, M.D., MHCM named as Institution’s Chief Quality Officer (CQO)
Thomas Aloia, M.D., MHCM, will expand on his current work and serve as the institution’s Chief Quality Officer (CQO).
Aloia has served as the interim CQO since July 2019, supporting and helping lead the institution through its federal regulatory and accreditation efforts.
This position builds upon the existing leadership roles in which Aloia serves, including his role as Chief Quality and Value Officer and head of the Institute for Cancer Care Innovation (ICCI). It also magnifies, aligns and solidifies the institutional prioritization and commitment to the highest level of quality, safety, continuous readiness and process excellence.
Dr. Aloia has proven himself to be a highly effective leader with strong emotional intelligence, drive and commitment to personal leadership development and high standards of professionalism. In addition to being a hepatobiliary surgical oncologist in the Gastrointestinal Center, he has successfully guided numerous efforts to elevate care at MD Anderson, including Surgery’s ACS NSQIP performance and the Enhanced Recovery Program.
Through is efforts, he will work in partnership with all leaders, faculty and staff to reinforce a culture that is not only continuously aware of opportunities to improve but also embraces them.
We congratulate Dr. Aloia on his newly attained role!
Dr. Ronald Walters Named New Board Chair for National Comprehensive Cancer Network
Vijaya Gottumukkala, M.D. named Institute for Cancer Care Innovation Associate Head
The Institute for Cancer Care Innovation (ICCI) is pleased to announce the appointment of Vijaya Gottumukkala, M.D., as an Associate Head of our institute effective January 1, 2019.
Dr. Gottumukkala has continuously provided insight to ICCI's value-based care initiatives and has served as co-lead to the Enhanced Recovery Program (ERP) at MD Anderson from its inception. He helped develop the first ERP initiatives that paved the way for the 17 ERP programs to be implemented at MD Anderson to date. His unwavering commitment to patient-centric, recovery-focused care plans positively impacts patients' ability to return to further treatment, if needed.
We congratulate and welcome Dr. Gottumukkala as a member of the ICCI leadership.